Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer.
about
Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancerHeterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategiesPrognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.Predictive biomarkers for checkpoint inhibitor-based immunotherapy.Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma.Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaInvestigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome.Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system.Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune MarkersSex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancerPrognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung
P2860
Q26740288-A71FA995-9AF5-4EA4-9ECA-2AB92B68FEADQ30275647-860A87E2-2347-4FBB-A22F-D2D43DB0FECEQ33591683-EF68237B-D472-4E24-952B-88F897A96668Q36358014-98C4B276-FC1A-489D-909B-0125ADBE0F57Q37665660-96F74769-9D75-4AC2-9366-330F3F53877AQ37697218-D5D14598-CBE4-4DFE-98E2-D6B1E41E656DQ38786289-41392ECD-9BCB-4924-95F0-E9F2D6E1D750Q40496586-1ADF5BE7-7A63-4F20-BF7C-2084BA01FCC3Q41092061-9D4A3539-6616-4EA0-9667-C9387C1BF883Q41701208-4D075B09-2F5F-42DD-AB78-AC58EF7B44D1Q41926342-E674AA7C-0505-454A-A5BD-51D81371A083Q46540302-4A779483-1FA1-4E4F-903D-6364200F8BE8Q47329066-74DFE4C9-A8AC-4056-B423-C843EF8C05A4Q48307824-E09FCBFC-554F-462D-BBE7-2DACEA4FD8C2Q50070316-77678EF3-1581-4DD2-A8C6-83191008EEA7Q54965295-7B31C660-13BF-4DB9-B29C-137DCDA615AEQ55263819-6F551A56-3A4D-4DCA-8838-F6EA3FA8C263Q55440274-34BF35A0-0C57-473D-B545-A0EDD3F0AC0EQ56892179-87A9AA51-6AD0-4169-8B47-E821A43FD24AQ58617545-3E1BC966-81D5-4841-B46A-F8C7A56BEBC9Q58733942-B15C8C7E-C2E1-417E-A955-08460D830304
P2860
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prognostic and predictive valu ...... th non-small cell lung cancer.
@ast
Prognostic and predictive valu ...... th non-small cell lung cancer.
@en
type
label
Prognostic and predictive valu ...... th non-small cell lung cancer.
@ast
Prognostic and predictive valu ...... th non-small cell lung cancer.
@en
prefLabel
Prognostic and predictive valu ...... th non-small cell lung cancer.
@ast
Prognostic and predictive valu ...... th non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Prognostic and predictive valu ...... th non-small cell lung cancer.
@en
P2093
Chuan-Miao Xie
Dong-Qiang Zeng
Qiu-Gen Hu
Ru-Zhi Zhong
Xiao-Yin Li
Yun-Fang Yu
P2860
P304
13765-13781
P356
10.18632/ONCOTARGET.7282
P407
P577
2016-02-09T00:00:00Z